1 Min Read
Feb 1 (Reuters) - BIOTEC PHARMACON ASA:
* Q4 REVENUE NOK 17.7 MILLION VERSUS NOK 18.2 MILLION YEAR AGO
* Q4 EBITDA LOSS NOK 7.2 MILLION VERSUS LOSS NOK 8.1 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.